Literature DB >> 7904305

Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation.

J L Hudson1, P Bickford, M Johansson, B J Hoffer, I Strömberg.   

Abstract

The ability of grafted fetal ventral mesencephalic dopaminergic (DAergic) neuroblasts to reinnervate the unilaterally DA denervated rat striatum and improve motoric asymmetry has been well documented in several laboratories. The importance of host target specificity, and catecholamine (CA) neurotransmitter species, in the ability of grafts to ameliorate rotational responses to apomorphine and to affect electrophysiological characteristics of striatal neurons has not been systematically studied. We unilaterally lesioned Sprague-Dawley rats with 6-hydroxydopamine (6-OHDA) and verified the lesions using apomorphine (0.05 mg/kg, s.c.)-induced rotational behavior. Some of the animals subsequently received, intrastriatally, either DA neuroblasts from ventral mesencephalon that normally innervate the striatum, or from arcuate nucleus that do not. Additionally, two other groups were included that received either a CAergic graft from the noradrenergic nucleus locus coeruleus or a graft of cerebral cortex, which normally projects to the striatum but does not contain CAergic neurons. Only the fetal ventral mesencephalic grafts were able to reduce apomorphine-induced rotations and normalize striatal cell firing rates; striatal cell firing rates with ventral mesencephalic grafts were 1.43 Hz +/- 0.22, with arcuate nucleus grafts were 6.03 +/- 0.73, with locus coeruleus grafts were 4.71 +/- 0.74, and with cerebral cortex grafts were 4.36 +/- 0.45. Moreover, only the ventral mesencephalic grafts produced a dense tyrosine hydroxylase (TH)-immunoreactive nerve terminal network in the striatum; in contrast, the arcuate nucleus grafts did not reinnervate the striatum. In locus coeruleus grafted striata, few very long TH-positive axons were seen. We thus conclude that target specificity and neurotransmitter type are critically important in the ability of a graft to functionally reinnervate the 6-OHDA denervated striatum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904305      PMCID: PMC6576860     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

Review 1.  Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Authors:  Sarah L Maxwell; Meng Li
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

2.  Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease.

Authors:  N Nakao; M Ogura; K Nakai; T Itakura
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

3.  Doublesex and mab-3-related transcription factor 5 promotes midbrain dopaminergic identity in pluripotent stem cells by enforcing a ventral-medial progenitor fate.

Authors:  Nicole Gennet; Emily Gale; Xinsheng Nan; Emma Farley; Katalin Takacs; Barbara Oberwallner; David Chambers; Meng Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

4.  Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

Authors:  Lachlan Thompson; Perrine Barraud; Elin Andersson; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 5.  Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.

Authors:  Curt R Freed; Wenbo Zhou; Robert E Breeze
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

6.  Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts.

Authors:  I Strömberg; M Johansson
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells.

Authors:  Ines Jaeger; Charles Arber; Jessica R Risner-Janiczek; Judit Kuechler; Diana Pritzsche; I-Cheng Chen; Thulasi Naveenan; Mark A Ungless; Meng Li
Journal:  Development       Date:  2011-08-31       Impact factor: 6.868

Review 8.  Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells.

Authors:  Emily Gale; Meng Li
Journal:  Mol Brain       Date:  2008-09-30       Impact factor: 4.041

9.  Early specification of dopaminergic phenotype during ES cell differentiation.

Authors:  Malin Parmar; Meng Li
Journal:  BMC Dev Biol       Date:  2007-07-18       Impact factor: 1.978

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.